A systematic review of the role of methylase genes in antibiotic resistance: co-existence with extended spectrum β-lactamase and carbapenemase genes in Klebsiella pneumoniae
Year: 2025
Type: review
Study design: Systematic Review
Abstract: Background Antibiotic resistance in multidrug-resistant Klebsiella pneumoniae (MDR-KP), particularly against carbapenems and colistin, is a critical concern, increasing morbidity and mortality among hospitalized patients. This systematic review aims to identify methylase genes in K. pneumoniae and examine their co-existence with β-lactamase and carbapenemase genes contributing to antibiotic resistance. Methods A literature search was conducted across three electronic databases from inception until 6 December 2023. The quality assessment followed Critical Appraisal Skills Programme (CASP) criteria. Studies focusing on methylase genes and antibiotic resistance in K. pneumoniae were included. Two authors independently screened titles, abstracts, and full texts, with a third resolving disagreements. Results Thirty-four studies met the inclusion criteria. Methylase genes in K. pneumoniae isolates were predominantly reported in Europe and Asia, particularly in Iran, China, Japan, and India (8.8%, N = 3). The most prevalent 16S rRNA methyltransferase genes identified were armA (76.5%, N = 26), rmtB (61.8%, N = 21), and rmtC (29.4%, N = 10). Common extended-spectrum β-lactamase (ESBL) genes included bla CTXM (64.7%, N = 22) and bla SHV (47%, N = 16), while bla KPC (26.5%, N = 9) and bla NDM (23.5%, N = 8) were the predominant carbapenemase genes. The coexistence of methylase genes with ESBL and carbapenemase genes conferred significant resistance to aminoglycosides (gentamicin, kanamycin, tobramycin, amikacin, arbekacin), cephalosporins (cefazolin, cefoxitin, cefotaxime), and carbapenems (imipenem, meropenem). Conclusions The widespread distribution of resistance mechanisms in K. pneumoniae highlights a global challenge, emphasizing the need for strategic antimicrobial use to reduce resistance rates.
Source: PeerJ
DOI: 10.7717/peerj.20428
Authors: Nur Husna Shahimi, Nabiha Bouafia, Mawaddah Mohd Azlan, Asma Nadia Ahmad Faris, Nur Ayunie Ahmad, Ali Rabaan, Amal Alfaraj, Bandar Albaradi, Tasneem Zaidan, Abdulsalam Alawfi, Amer Alshengeti, Zainab Almansour, Wadha Alfouzan, Amal Sabour, Maha Alshiekheid, Anizah Rahumatullah, Nik Yusnoraini Yusof
Institutions: Universiti Sains Malaysia, Riyadh Armed Forces Hospital, University of Sousse, Alfaisal University, Saudi Aramco Medical Services Organization, University of Haripur, King Fahad Specialist Hospital, King Abdulaziz Hospital, Taibah University, Prince Mohammed bin Abdulaziz Hospital, National Guard Health Affairs, King Faisal University, Farwaniya Hospital, Kuwait University, King Saud University
Language: English
Subfield: Molecular Medicine
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $1,395
OpenAlex ID: W4417451372
